Published • loading... • Updated
Medicare GLP-1 Discount Has One Catch: Some Sick Patients Don’t Qualify
The temporary program caps copays at $50 a month as CMS evaluates broader coverage and potential Medicare spending impacts.
Summary by The Billings Gazette
9 Articles
9 Articles
In January, Jeff La Marca received a prescription for Zepbound, the popular weight-loss drug. But he couldn't afford the $750 a month it cost. Then Medicare launched an 18-month pilot program offering GLP-1 drugs to some enrollees for just $50 a month. La Marca thought that, finally, he could afford it.
·San Diego, United States
Read Full Article
Medicare launches a $50-a-month fixed copay for Wegovy, Zepbound and Fondayo from July 2026. This is what beneficiaries should know about eligibility, enrollment, and program boundaries.
Coverage Details
Total News Sources9
Leaning Left1Leaning Right0Center8Last UpdatedBias Distribution89% Center
Bias Distribution
- 89% of the sources are Center
89% Center
11%
C 89%
Factuality
To view factuality data please Upgrade to Premium
